Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule I - Condensed Statements of Cash Flow (Details)

v3.25.0.1
Schedule I - Condensed Statements of Cash Flow (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 20,845 $ 34,566 $ 71,978
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Deferred income taxes (12,796) (4,680) 22,300
Foreign currency loss and interest related to intercompany balances 35 29 227
Gain from issuance of shares as payment of deferred consideration related to business acquisition (2,681) 0 0
Share-based compensation 12,339 15,015 12,161
Other operating activities, net 125 2,631 775
Changes in assets and liabilities:      
Decrease (increase) in other current assets 13,893 (29,386) 1,476
Increase (decrease) in other current liabilities (2,820) 990 6,884
Net cash provided by operating activities 221,858 136,094 209,256
Cash flows from investing activities:      
Net cash used in investing activities (114,858) (296,822) (175,488)
Cash flows from financing activities:      
Common stock repurchased (31,989) (33,694) (40,042)
Dividends paid on common stock (14,015) (14,272) (10,893)
Dividends paid on redeemable preferred stock (5,750) (5,750) (5,750)
Payment of Ares Put Option 0 (9,808) 0
Net cash (used in) provided by financing activities (56,004) 85,357 10,555
Cash and cash equivalents and restricted cash, beginning of year 241,421 316,769 272,543
Cash and cash equivalents and restricted cash, end of year 292,408 241,421 316,769
Supplementary cash flow information:      
Cash received for interest 9,485 7,944 1,964
Cash paid for interest 92,103 82,477 57,653
Cash paid for taxes 10,422 29,456 6,747
Supplementary noncash activities:      
Prepaid insurance premiums financed through notes payable 7,703 10,711 6,668
Issuance of shares as payment of deferred consideration related to business acquisition 22,319 0 0
Parent Company      
Cash flows from operating activities:      
Net income 20,845 34,369 71,747
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity income from subsidiaries (11,047) (29,766) (74,024)
Deferred income taxes (3,320) 298 (164)
Amortization of deferred financing costs and debt discount 831 785 759
Foreign currency loss and interest related to intercompany balances 0 0 1,693
Gain from issuance of shares as payment of deferred consideration related to business acquisition (2,681) 0 0
Share-based compensation 1,693 1,172 955
Fair value adjustment of financial liabilities (11,338) (10,520) (887)
Other operating activities, net 0 (116) 0
Changes in assets and liabilities:      
Decrease (increase) in other current assets 24,679 4,856 (11,542)
Increase (decrease) in other current liabilities 1,193 (2,910) 6,752
Net cash provided by operating activities 20,855 (1,832) (4,711)
Cash flows from investing activities:      
Repayments of loans to subsidiaries and other investees 0 0 40,000
Distribution from subsidiary 0 0 28,109
Net cash used in investing activities 0 0 68,109
Cash flows from financing activities:      
Common stock repurchased (31,989) (33,694) (40,042)
Dividends paid on common stock (14,015) (14,272) (10,893)
Dividends paid on redeemable preferred stock (5,750) (5,750) (5,750)
Loans from investees 30,000 0 0
Payment of Ares Put Option 0 (9,808) 0
Repayment of long-term debt (1,184) (1,145) (1,500)
Net cash (used in) provided by financing activities (22,938) (64,669) (58,185)
Net (decrease) increase in cash and cash equivalents and restricted cash (2,083) (66,501) 5,213
Cash and cash equivalents and restricted cash, beginning of year 27,220 93,721 88,508
Cash and cash equivalents and restricted cash, end of year 25,137 27,220 93,721
Supplementary cash flow information:      
Cash received for interest 23,575 25,623 26,028
Cash paid for interest 23,084 23,089 24,610
Cash paid for taxes 0 0 735
Supplementary noncash activities:      
Prepaid insurance premiums financed through notes payable 1,101 671 1,145
Issuance of shares as payment of deferred consideration related to business acquisition $ 22,319 $ 0 $ 0